Hyperlipidaemia and Lip erosion

Summary:

Lip erosion is found among people with Hyperlipidaemia, especially for people who are female, 60+ old.

The study analyzes which people have Lip erosion with Hyperlipidaemia. It is created by eHealthMe based on reports of 13 people who have Hyperlipidaemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hyperlipidaemia?

Hyperlipidaemia (presence of excess lipids in the blood) is found to be associated with 1,428 drugs and 1,407 conditions by eHealthMe. Check the latest studies of Hyperlipidaemia.

What is Lip erosion?

Lip erosion (peeling off of lip) is found to be associated with 156 drugs and 395 conditions by eHealthMe. Check the latest studies of Lip erosion.



On Jul, 13, 2026

13 people who have Hyperlipidaemia and Lip Erosion are studied.

Would you have Lip erosion when you have Hyperlipidaemia?

Gender of people who have Hyperlipidaemia and experienced Lip Erosion *:

  • female: 83.33 %
  • male: 16.67 %

Age of people who have Hyperlipidaemia and experienced Lip Erosion *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 8.33 %
  • 50-59: 33.33 %
  • 60+: 58.33 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 7 people, 53.85%
  2. Bipolar Disorder (mood disorder): 4 people, 30.77%
  3. Diabetes: 4 people, 30.77%
  4. Insomnia (sleeplessness): 4 people, 30.77%
  5. Urination - Painful: 3 people, 23.08%
  6. Gastric Ulcer (stomach ulcer): 3 people, 23.08%
  7. Affect Lability (emotional incontinence): 3 people, 23.08%
  8. Blood Uric Acid Increased: 3 people, 23.08%
  9. Constipation: 3 people, 23.08%
  10. Enlarged Prostate: 3 people, 23.08%

Common drugs taken by these people *:

  1. Lipitor: 8 people, 61.54%
  2. Lamictal: 6 people, 46.15%
  3. Januvia: 4 people, 30.77%
  4. Glyburide: 4 people, 30.77%
  5. Adalat Cc: 3 people, 23.08%
  6. Abilify: 2 people, 15.38%
  7. Amlodipine Besylate: 2 people, 15.38%
  8. Dutasteride: 2 people, 15.38%
  9. Valproate Sodium: 2 people, 15.38%
  10. Febuxostat: 2 people, 15.38%

Common symptoms for these people *:

  1. Oral Mucosa Erosion (erosion of mouth mucous membrane): 11 people, 84.62%
  2. Fever: 9 people, 69.23%
  3. Rashes (redness): 7 people, 53.85%
  4. Erythema Multiforme (a type of hypersensitivity reaction): 6 people, 46.15%
  5. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 6 people, 46.15%
  6. White Blood Cell Count Increased: 5 people, 38.46%
  7. Constipation: 4 people, 30.77%
  8. Oedema Peripheral (superficial swelling): 4 people, 30.77%
  9. Vision Blurred: 4 people, 30.77%
  10. Hypokalemia (low potassium): 4 people, 30.77%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Lip erosion?

- Check whether Lip erosion is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Lip erosion:

All the conditions that are associated with Lip erosion:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Lip erosion and Hyperlipidaemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: